Literature DB >> 8277264

An immunodominant cytotoxic T cell epitope on the VP7 rotavirus protein overlaps the H2 signal peptide.

M A Franco1, I Prieto, M Labbé, D Poncet, F Borras-Cuesta, J Cohen.   

Abstract

C57BL/6 (H-2b) mice were primed with the bovine RF strain of rotavirus to study the induction of CD8+ cytotoxic T lymphocytes (CTLs). These rotavirus-specific CTLs were detected only after in vitro restimulation with the virus. Using a recombinant vaccinia virus we identified the RF VP7 protein as a major target of these CTLs. The response against this protein was obtained also after in vitro restimulation with simian SA11 and human WA strains of rotavirus. Using published Db and Kb allele-specific motifs to predict possible CTL epitopes in the RF VP7 protein, we synthesized and tested 18 predicted peptides of VP7. Only one peptide was able to sensitize target cells at a concentration below 5 x 10(-7) M. This CTL epitope was also induced by immunization with the RF VP7 expressed with a baculovirus vector, and was shown to be immunodominant by its capacity to inhibit, in an unlabelled target assay, the bulk response against cells infected with recombinant vaccinia virus expressing VP7. This CTL epitope overlaps the H2 signal peptide of the protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8277264     DOI: 10.1099/0022-1317-74-12-2579

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  14 in total

1.  Geometric mismatches within the concentric layers of rotavirus particles: a potential regulatory switch of viral particle transcription activity.

Authors:  Sonia Libersou; Xavier Siebert; Malika Ouldali; Leandro F Estrozi; Jorge Navaza; Annie Charpilienne; Pascale Garnier; Didier Poncet; Jean Lepault
Journal:  J Virol       Date:  2008-01-09       Impact factor: 5.103

2.  Sequence and phylogenetic analysis of the VP7 gene of a bovine rotavirus with G6 subtype.

Authors:  S Mummidi; P S Paul; R E Holland
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

3.  Characterization of homologous and heterologous rotavirus-specific T-cell responses in infant and adult mice.

Authors:  María C Jaimes; Ningguo Feng; Harry B Greenberg
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  G3P2 rotaviruses causing diarrhoeal disease in neonates differ in VP4, VP7 and NSP4 sequence from G3P2 strains causing asymptomatic neonatal infection.

Authors:  C D Kirkwood; B S Coulson; R F Bishop
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

5.  Attenuated poliovirus strain as a live vector: expression of regions of rotavirus outer capsid protein VP7 by using recombinant Sabin 3 viruses.

Authors:  N M Mattion; P A Reilly; S J DiMichele; J C Crowley; C Weeks-Levy
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

Review 6.  MHC ligands and peptide motifs: first listing.

Authors:  H G Rammensee; T Friede; S Stevanoviíc
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

7.  The concentration of Ca2+ that solubilizes outer capsid proteins from rotavirus particles is dependent on the strain.

Authors:  M C Ruiz; A Charpilienne; F Liprandi; R Gajardo; F Michelangeli; J Cohen
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

8.  Evidence for CD8+ T-cell immunity to murine rotavirus in the absence of perforin, fas, and gamma interferon.

Authors:  M A Franco; C Tin; L S Rott; J L VanCott; J R McGhee; H B Greenberg
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

9.  alpha(4)beta(7) independent pathway for CD8(+) T cell-mediated intestinal immunity to rotavirus.

Authors:  N A Kuklin; L Rott; J Darling; J J Campbell; M Franco; N Feng; W Müller; N Wagner; J Altman; E C Butcher; H B Greenberg
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

10.  Growth of rotaviruses in primary pancreatic cells.

Authors:  Barbara S Coulson; Paul D Witterick; Yan Tan; Marilyn J Hewish; Joanne N Mountford; Leonard C Harrison; Margo C Honeyman
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.